ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2096

Nailfold Capillaroscopy Is an Opportunity for Telerheumatology

Jacob R. Stever1, Nicholas Lebedoff2, Tracy M. Frech3, Lesley A. Saketkoo4 and Marcus Snow5, 1Salt Lake City VA Medical Center and University of Utah, Salt Lake City, UT, 2Internal Medicine, University of Utah, Salt Lake City, UT, 3Division of Rheumatology, University of Utah, Salt Lake City, UT, 4Rheumatology, Tulane University School of Medicine, New Orleans, LA, 5Internal Medicine, University of Nebraska, Omaha, NE

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Capillaroscopy, education and technology, Raynaud's phenomenon

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: The 2013 classification criteria for systemic sclerosis (SSc) provide 2 points (towards a 9 point diagnosis) for patients who have abnormal capillaroscopy. In the United States (U.S.), formal capillaroscopy training programs do not exist as part of fellowship training for assessment of patients complaining of Raynaud’s phenomenon. There is an effort in the European Union League Against Rheumatism (EULAR) microcirculation group to introduce training and certification for capillaroscopy in the United States (U.S.). The purpose of this project was to assess if U.S. trainees at a single center could effectively use nailfold videocapillaroscopy (NVC) with non-formal educational training provided by a local expert and through remote store-it-forward telehealth send images for additional teaching at other U.S. SSc centers. Additionally, the quality of dermatoscope images were compared to NVC to assess the role of this device for image capture.

Methods: Two trainees (JS and NL) had health related training in capillaroscopy, which involved observation and then hands-on performance of nailfold video capillaroscopy (NVC, Optilia®) and dermatoscope (Dermalite®) capillaroscopy on SSc registry patients. Subsequently 20 SSc patients had two NVC (Optilia®) and dermatoscope (Dermalite®) capillaroscopy on 8 digits obtained (Figure 1). These 153 images (2 patients had multiple auto-amputation) were interpreted by the two trainees and then sent to 2 U.S. members of the EULAR microcirculation group to determine whether normal versus abnormal could be effectively obtained and determined by dermatoscope, and whether trainees could identify abnormal features of NVC.

Results: The inter-rater reliability of the 153 NVC images was 0.82. Based on the NVC images all 20 patients would have been appropriately referred to a SSc center for further evaluation, but 29 images had additional abnormality features (micro-hemorrhage and neo-angiogenesis) found by the expert reviewers. Dermatoscope was able to recognize abnormal capillaroscopy in 13 of the 20 patients (65% of the time; Figure 1).

Conclusion: Store-it-forward capillaroscopy image capture with expert read is a potential modality to integrate nailfold capillaroscopy into U.S. fellowship training programs. While NVC is the gold-standard device for capillaroscopy, dermatoscope can be effectively used to evaluate the complaint of Raynaud’s phenomenon. This pilot suggests that nailfold capillaroscopy is an opportunity to integrate telehealth technology into rheumatology practice and educational curriculums.


Disclosure: J. R. Stever, None; N. Lebedoff, None; T. M. Frech, None; L. A. Saketkoo, None; M. Snow, None.

To cite this abstract in AMA style:

Stever JR, Lebedoff N, Frech TM, Saketkoo LA, Snow M. Nailfold Capillaroscopy Is an Opportunity for Telerheumatology [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/nailfold-capillaroscopy-is-an-opportunity-for-telerheumatology/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/nailfold-capillaroscopy-is-an-opportunity-for-telerheumatology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology